ABSTRACT
Klippel‐Trénaunay‐Weber syndrome (KTW) is a rare congenital disease, representing a challenge in prenatal diagnosis due to overlapping characteristics with other syndromes and no specific genetic markers known to date. We have collected all the cases present in the literature on the prenatal diagnosis of KTW, emphasizing common ultrasound findings that can guide the clinician and genetics to the prenatal counseling. Thus, we collected all the information about the postnatal prognosis and the necessity for treatment. Our review of 44 cases highlights the typical common features: hemihypertrophy, predominantly affecting the right leg, with cystic lesions extending to the trunk or upper limbs and rare internal organ involvement. Prenatal complications, including hydrops and polyhydramnios, emphasize the need for a careful ultrasound follow‐up. Despite no identified genetic mutation, genetic counseling and invasive testing are recommended. Mortality rate due to a severe complication known as Kasabach‐Merritt syndrome, underlines the importance of early diagnosis and accurate management strategies. Prenatal diagnosis of KTW, guided by ultrasound findings and genetic counseling, could help with informed decision‐making and optimal care planning.
Keywords: hemihypertrophy, Klippel‐Trénaunay, overgrowth syndrome, prenatal diagnosis
This meta‐analysis demonstrates the high diagnostic accuracy of SZ‐CEUS for differentiating between malignant and benign focal liver lesions, as well as for HCC from non‐HCC lesions. The study shows better performance for smaller lesions and those with a higher proportion of malignancy.

1. Introduction
The Klippel‐Trénaunay‐Weber syndrome (KTW), also known as “hemangiectatic hypertrophy syndrome” and “angio‐osteohypertrophy syndrome”, is a rare and congenital disease, first described by Maurice Klippel and Paul Trénaunay in 1900. The incidence has been estimated at around 2–5:100000 [1]. This syndrome has a sporadic incidence without any racial or sex predilection [2] and it is characterized by typical features: port wine stains/capillary, venous malformation or varicosities, and limb hypertrophy [3].
Prenatal diagnosis can be challenging, due to the overlapping with other overgrowth syndromes; thus, a specific related genetic mutation has not been recognized, leading to a difficult genetic diagnosis [4].
Prenatal diagnosis can help the couple whether to continue the pregnancy and to program the birth and the successive follow‐up and surgical planning.
We report a review of the literature of prenatally diagnosed cases, to describe the most common ultrasound features, the risk of heart failure developing in utero, polyhydramnios and hydrops, and postnatal prognosis.
2. Material and Methods
The literature search was conducted using Web of Science, Scopus, MEDLINE, and Embase, as electronic databases from the inception of each database to February 2024, utilizing combinations of the relevant medical subject heading (MeSH) terms, key words, and word variants for: “Klippel–Trénaunay–Weber syndrome” and “prenatal diagnosis”. A review of articles also included the abstracts of all references retrieved from the search.
Inclusion criteria were prenatal diagnosis assessment of KTW cases. Only studies reporting the KTW description and the ultrasound features were eligible for the review. Two authors (GO and AA) reviewed all abstracts independently. Agreement regarding potential relevance was reached by consensus with authors. Full‐text copies of those articles were obtained, and the same two reviewers independently extracted relevant data. Inconsistencies were discussed and consensus was reached, or the dispute was resolved by discussion with the senior author (GMM). PRISMA guidelines were followed. Only full‐text and English‐written articles were considered eligible for inclusion.
3. Results
Thirty‐six articles of case reports of prenatal diagnosis of KTW syndrome were found, including 44 cases, eligible for inclusion in our review (Table 1—Figure 1) [4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39].
TABLE 1.
Case reports of prenatal diagnosis of KTW.
| Paper number | Year | Author | Age | G.A. at diagnosis | Fetal anemia | Limb involvement | Trunk involvement | Neck/head involvement | Upper arms | Extension | Internal organs involvement | Histologic diagnosis of the lesions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2023 | GICA N. | NN | 26 | No | Left | Yes | No | No | Left buttock, pelvic area | — | Port wein stain |
| 2 | 2023 | SINGH (case 1) | 26 | 39 | No | Right | Yes | No | No | Glutall region | No | Low‐flow vascular malformation |
| SINGH (case 2) | 25 | 18 | Yes | Right | No | No | No | No | No | Hemang‐ioma | ||
| SINGH (case 3) | 33 | 23 | No | Left | No | No | No | No | No | NN | ||
| SINGH (case 4) | 36 | 31 | Yes | Right | No | No | No | No | No | NN | ||
| 3 | 2006 | PENG (case 1) | 22 | 28 | No | Left | Yes | No | No | Left back | Port wein stain | |
| PENG (case 2) | 26 | 35 | Yes | Right | No | No | No | No | Hemangioma | |||
| 4 | 2013 | CAKIROGLU | 27 | 26 | No | Right | Yes | No | No | Scrotum, lower trunk | Port wein stain | |
| 5 | 2021 | HOU‐QING | 25 | 18 | No | Right | No | No | No | No | NN | |
| 6 | 2014 | TANAKA | 27 | 25 | Yes | Both legs | Yes | No | No | Chest, retroperitoneum | Hemangioma, port wein stains | |
| 7 | 2020 | DONGMEI | 26 | 17 | No | Left | No | No | No | No | Port wein stains | |
| 8 | 1998 | PALADINI (case1) | 21 | 17 | No | Right | Yes | No | No | Right iliac fossa | Hemangioma of bowel liver, kidneys | Hemangioma |
| PALADINI (case2) | 23 | 18 | Yes | Right | Yes | No | Yes | abdomen, trunk (axillar mass) | NN | |||
| 9 | 1992 | HEYDANUS | 34 | 20 | No | Right | Yes | No | No | Right buttock, hip | Hemangioma | |
| 10 | 2006 | Chih‐Ping | 35 | 22 | No | Right | Yes | No | No | Abdomen | Hemangioma | |
| 11 | 1994 | Jorgenson | 30 | 19 | No | Left foot | No | No | No | No | Hepatic hemangioma | Hemangioma |
| 12 | 2000 | Goncalves | 28 | 30 | No | Right | Yes | No | No | Right buttock, flank | Port wein stains | |
| 13 | 2003 | Sahinoglu | 18 | 24 | No | Left | No | No | No | No | Hemangioma | |
| 14 | 1991 | Drose | 24 | 29 | No | Right | No | No | No | No | NN | |
| 15 | 1983 | Warhit | 30 | 20 | No | Left | Yes | No | No | Buttock, foot | Varicous, hemangioma | |
| 16 | 2003 | Assimakopoulos | 36 | 22 | No | Left | Yes | No | No | Abdome, thorax, gluteus | Bowel hemangioma | Port wein stains |
| 17 | 2009 | Coombs | 32 | 24 | No | Both legs | Yes | No | No | Retroperitoneum, pelvis | — | Bilaral agenesia of part femoral vein, popliteal veins |
| 18 | 1981 | Hatjis | 34 | 30 | No | Left | Yes | No | No | Thorax, abdomen | — | Cutaneous hemangioma |
| 19 | 1993 | Hayashi | 26 | 19 | No | NN | Yes | No | No | Buttock, lower abdomen | No | Hemangiolinfangioma |
| 20 | 2019 | Ivanitskaya (case1) | 21 | 20 | No | Left | Yes | No | Yes | Thorax, dorsum, abdomen, both buttock, axillary region | Right lung solid mass 15×12×12 mm, solid mass abdomen 6 mm | Port wine stains |
| Ivanitskaya (case 2) | 36 | 32 | No | Left | Yes | No | No | Lumbar region, buttcock | Port wine stains | |||
| Ivanitskaya (case 3) | 31 | 24 | No | Left | Yes | No | Yes | Left buttock, low abdomen | Port wine stains—vein varicose | |||
| Ivanitskaya (case 4) | 31 | 29 | No | Right arm | Yes | No | Yes | Right thorax, right arm mixed cystic and solid structure, right shoulder and forearm | Right lung solid mass | NN | ||
| 21 | 1986 | Lewis | 25 | 22 | No | Both legs | Yes | No | Yes | Abdomen, chest wall, left forearm, buttocks thighs, retroperitoneum | Azygos vein, pericardium | Hemangiomas |
| 22 | 1991 | Meholic | 28 | 23 | No | Left arm | Yes | No | Yes | Chest wall, lower abdomen, pelvis | — | Hemangiomas |
| 23 | 1994 | Meizner | 41 | 15 | No | Right | Yes | No | No | Sacro coccigeal region, left chest wall | No | Hemangiomas, varicosities of abdominal wall |
| 24 | 1988 | Mor | 31 | 30 | Yes | Right | No | No | No | No | No | Port wine stains |
| 25 | 1984 | Seoud | 36 | 17 | No | NN | Yes | Yes | No | Upper abdomen and neck | No | Hemangiomas |
| 26 | 1988 | Shalev | 28 | 33 | No | Right | Yes | No | Yes | Abdomen, left arm | No | Hemangiomas |
| 27 | 1993 | Yancey | 22 | 26 | No | Left | Yes | Yes | No | Cystic and solid, multiloculated anterior neck mass | No | Hemangiomas |
| 28 | 1994 | Yancowitz | 27 | 17 | No | Right | Yes | Yes | Yes | Eedema of rigth body | No | NN |
| 29 | 2001 | Zoppi | 28 | 28 | Yes | Right | Yes | No | No | Hypoechoic and anechoic areas, right abdomen, sacral and perineal area | Bowel, right kidney involved | Hemangiomas, port wine stains |
| 30 | 1998 | Shih | 32 | 15 | No | Left | No | No | No | No | Hemangiomas | |
| 31 | 1999 | Christenson | 34 | 34 | No | Right | Yes | No | No | Retroperitoneum | Port wein stains | |
| 32 | 1999 | Roberts | 26 | 19 | No | Left | Yes | No | Yes | chest, right arm | Hemangiomas | |
| 33 | 2001 | Martin | 21 | 20 | No | Left | Yes | Yes | No | Torax, neck, scalp, retroperitoneum | Hemangiomas | |
| 34 | 2000 | Meja | NN | 20 | No | Right | Yes | No | No | No | Intestine | NN |
| 35 | 2009 | Volkow | NN | 22 | No | Arms | Yes | No | Yes | No | No | NN |
| 36 | 2011 | Al Asali | NN | 22 | No | Both legs | No | No | No | No | No | NN |
| Paper number | Hydrops | Polihydra mnios | Prenatal invasive diagnosis | Karyotype | Familiarity | G.A. at birth | Pregnancy outcome | Weight at birth | Associated anomalies | Neonatal outcome | Cause of death | Treatment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | No | Yes | No | No | No | 39 | CS | 3200 | No | Normal at 6 months | NN | |
| 2 | No | No | No | No | No | 40 | SD | 2600 | Fgr | Normal at 4 year | Scleroth‐erapy | |
| No | No | No | No | No | TOP | No | ||||||
| No | No | No | No | No | TOP | No | ||||||
| Yes | Yes | No | No | No | 33 | IUD | 2400 | No | ||||
| 3 | No | Yes | Yes | 46,XY | No | 37 | CS | 2840 | No | Death in 10 days of life | Kasabach‐Merrit syndrome | |
| Yes | No | No | 46,XX | No | 35 | SD | 3340 | No | Death in 15 days of life | Cardiomegaly, thrombocitopenia | ||
| 4 | No | No | Yes | 46,xy | No | TOP | No | |||||
| 5 | No | No | Yes | 46,XX | No | TOP | No | |||||
| 6 | Yes | Yes | No | No | No | 28 | CS | 1954 | No | Death in first day | Kasabach‐Merrit syndrome | |
| 7 | No | No | Yes | LOH for 1q21.2 q44 | No | TOP | Umbilical cord hemangioma and cyst | |||||
| 8 | No | No | No | No | No | TOP | No | |||||
| No | Yes | No | No | No | TOP | No | ||||||
| 9 | No | No | Yes | NORMAL | No | TOP | No | |||||
| 10 | No | No | Yes | 46,XY | No | 36 | SD | 3268 | No | Normal at 2 months | NN | |
| 11 | No | No | Yes | NORMAL | Yes | TOP | No | |||||
| 12 | No | Yes | No | No | No | 37 | CS | 3210 | No | Normal at 9 months | NN | |
| 13 | No | No | Yes | 46,XX | No | 26 | PS | Umbilical cord hemangioma | Death in first day | NRDS | ||
| 14 | No | Yes | Yes | 46,XX | No | 33 | CS | 3110 | Macrosomia, cardiomegalia, Hepatomegaly, cisterna magna obliteration, mild ventriculomegaly | Death in first day | ||
| 15 | No | No | No | No | No | 39 | CS | 4000 | No | Normal at 3 years | NN | |
| 16 | No | No | Yes | NORMAL | No | 38 | SD | 3200 | Bowel obstruction | Normal at 13 months | NN | |
| 17 | No | No | Yes | 46,xy | No | 39 | CS | — | Right foot syndactily, hypertrofy left hallux | Normal at 7 months | NN | |
| 18 | No | Yes | Yes | NORMAL | No | 37 | SD | 2470 | Normal at 10 mesi | Spontaneous resolution | ||
| 19 | No | Yes | Yes | 46,XY | No | TOP | No | |||||
| 20 | No | Yes | No | No | No | TOP | Right diaphragmatic hernia, cystic hygroma | |||||
| No | No | No | No | No | 39 | SD | 3750 | Abnormal placement of toes | Death in 2 day | Kasabach‐Merrit syndrome | ||
| No | No | No | No | No | TOP | No | ||||||
| No | No | No | No | No | TOP | Ectrodactily right hand, hyoerechogenic bowel, ascites | ||||||
| 21 | No | No | Yes | NORMAL | No | TOP | Cataracts of both eyes | |||||
| 22 | No | No | No | No | 40 | SD | 3078 | No | Alive at 4 months | NN | ||
| 23 | No | No | No | No | No | TOP | Absence of right foot | |||||
| 24 | Yes | Yes | Yes | NORMAL | No | 37 | CS | 3690 | No | Normal at six months | NN | |
| 25 | No | No | Yes | NORMAL | No | TOP | No | |||||
| 26 | No | Yes | Yes | 46,XX | No | 33 | SD | 4200 | Hypertrophy of right femur | Death in 4 day | Heart failure | |
| 27 | No | Yes | Yes | NORMAL | No | 35 | SC | — | Bilateral syndactily | Death at 5 months | ||
| 28 | No | No | Yes | NORMAL | No | 0 | TOP | Hydrocephaly | ||||
| 29 | No | No | No | No | No | 32 | CS | 2740 | Criptorchidism | Died after 8 h | ||
| 30 | No | No | No | No | No | TOP | No | |||||
| 31 | no | no | no | no | yes | 34 | CS | 3177 | Hepatomegaly | Amputation right leg | Embolization, cardioovascular decompression, amputation right hip | |
| 32 | No | No | No | No | No | 37 | CS | 3385 | No | Excision thoracic lesion | ||
| 33 | No | No | Yes | 46, XY | No | 0 | TOP | No | ||||
| 34 | No | No | No | No | No | NN | SD | No | NN | |||
| 35 | No | No | No | No | No | 0 | TOP | |||||
| 36 | No | Yes | No | No | No | NN | SD | NN | Talipes equino‐varus,abductiont of the thumb and sindactil‐y right hand |
FIGURE 1.

PRISMA 2020 flow diagram for new systematic reviews which included searches of databases and registers only (n. 99 Embase; n. 44 Pubmed; n. 33 Web of Science).
General characteristics including family history, gestational age at diagnosis, familiarity, hemihypertrophy side, extension of the lesion (involvement of trunk, upper arms, and neck), the involvement of internal organs, presence of cardiac failure with hydrops and/or polyhydramnios, presence of associated anomalies, fetal karyotype, fetal and neonatal outcomes, treatment have been summarized in Table 1. The median maternal age was 28 years old and the median gestational age at diagnosis was 22 weeks. We found only one case with positive familiar history, where the mother was affected.
According to prenatal cases described in the literature, the lesion first involves the legs, predominantly the right side (n = 18) (40%), while the left side is the primary origin in 36% (n = 16).
In only three cases (6.8%), there was a primary lesion of other parts of the fetal body, not including the lower limbs (isolated involvement of left foot and upper limbs with thorax).
In 13 cases (29.5%), the lesion did not extend outside the leg. When the lesion extends outside the leg, it generally involves the trunk, and it can reach the upper arms. We found 11 cases of involvement of upper arms (25%). In 4 cases (9%), there were cystic lesions of the neck.
Internal organs were rarely involved: in fact, only in seven cases (15.9%), suspected hemangioma of the lungs, bowel, kidneys, and liver has been reported. In two cases, there was an association with umbilical cord hemangioma. Associated anomalies were found in 17 of 44 cases (38.6%); the most frequent were limb anomalies (7/17, 41% of cases), including ectrodactyly, femur hypertrophy, syndactyly, foot agenesia, and talipes equinovarus.
Fetal traditional karyotype was performed in 20 cases (45.4% of cases), and in only one case, a mutation was found with loss of heterozygosity (LOH) for 1q21.2 q44.
In four cases (9%), the fetus developed hydrops, which seemed not related to the extension of the lesion: in only one case of hydropic fetus, the lesion extended from the lower limb toward the thorax. Among the cases of fetal hydrops, one case had a stillbirth at 33 weeks; one had spontaneous vaginal delivery at 35 weeks, with neonatal death after 15 days for cardiac failure and thrombocytopenia; one case underwent urgent cesarean section at 28 weeks, and the neonate died in the first day of life because of Kasabach‐Merrit syndrome; in the fourth case, cesarean section was performed at 37 weeks for anasarca, and the neonatal outcome was regular at 6 months of life. Polyhydramnios developed in 31.8% of cases (14/44).
In 20 of 44 cases (47.7%), the couple opted for termination of pregnancy (TOP). In the remaining 24 cases, in which the couple was committed to the pregnancy, the median gestational age at birth was 36 weeks (range 28–40), with one intrauterine death at 33 weeks' gestation. The neonatal outcome was reported in 20 of 23 cases. Nine babies (37%) died in the first 5 months of life: four cases due to Kasabach‐Merrit syndrome, one case for heart failure, one case for respiratory distress, and in three cases, the cause of death is unknown.
In 11 of 24 newborns (45%), the outcome was good. In one case, spontaneous resolution of the hemangioma of the left leg and trunk is reported; in one case, sclerotherapy treatment of the lesion was performed and one case had amputation of the leg. In the other eight cases, the need for treatment is not reported, but the outcome reported is good.
4. Discussion
Prenatal diagnosis of KTW can be challenging, due to rarity of the pathology and its overlapping with other genetic syndromes. There is currently no such large collection of prenatal diagnosed cases of KTW in the literature. Our aim was to collect all case reports of prenatal diagnosis of KTW, confirmed after birth, to recognize common ultrasound signs and help clinicians with this complex prenatal diagnosis.
The KTW syndrome is a rare and congenital disease, with an incidence estimated at two to five per 100 000 [1].
This syndrome has a sporadic incidence without any racial or sex predilection, [2] and it is characterized by typical features: port wine stains/capillary hemangiomas due to abnormal ectasis capillaries in the papillary dermis (presenting as red or purple marks that are irregular but may have a comparatively linear border) (98%), venous malformation or varicosities (72%), and limb hypertrophy (67%) [3].
It belongs to a spectrum of limb overgrowth syndromes (PROS), with whose members it shares many similarities.
Differential diagnosis includes Proteus syndrome, which is a genetic mosaic overgrowth disorder characterized by progressive and segmental overgrowth of any affected body tissue. The syndrome is caused by a postzygotic, mosaic‐activating mutation in AKT1 [40], and in rare prenatal cases, it presents a focal overgrowth, without hemihypertrophy, but associated with skeletal and central nervous system anomalies. An exome sequencing can detect mosaic mutation of AKT1 gene [41].
Parkes‐Weber syndrome (PWS) is characterized by the same triad of malformations of KTS combined with arteriovenous fistula [42].
Postnatal KTS diagnosis is easy, and it generally depends on two of the following features of the classical triad of KTS. According to Oduber et al, [43] KTS diagnosis can be clinically diagnosed in postnatal life considering two groups of (symptoms: A) congenital vascular anomalies: capillary (port wine stains), venous (hypoplasia/aplasia of veins, persistent embryonic veins), and lymphatic and B. changing limb sizes (hypertrophy or hypotrophy). If at least one of the group A and one of the group B are present, diagnosis can be made.
In postnatal series, the lower limb is the site of malformations in approximately 95% of patients; lymphatic and venous malformations lead to an overgrowth of the affected limb, with hypertrophy. Enlargement of the extremity consists of bone elongation, circumferential soft‐tissue hypertrophy, or both [44].
Between varicosities, the pathognomonic sign is the persistence of lateral (embryonic) vein, which can be seen in 56% of patients affected [3]. Embryonic veins are easily recognized in postnatal life with MRI and venous doppler.
Bilateral and truncal involvement are rare [45]. Viscera can be affected, with genitourinary involvement in 30% of cases and gastrointestinal in 20% [46, 47]; other visceral vascular malformations can be seen in the liver, retroperitoneum, and pericardium, leading to hemorrhagic complications of the organs involved [45].
Craniofacial and brain anomalies can rarely occur [26, 48].
KTW syndrome can be associated with limb anomalies in about 29% of cases [2].
Redondo et al. described 51 patients with KTS, 17 of which had abnormalities of the hand and/or foot [49].
If large enough, the cutaneous lesions may sequester platelets, possibly leading to Kasabach‐Merritt syndrome, a type of consumptive coagulopathy [50].
The KTW has a sporadic occurrence, with mosaic distribution. It is mostly a sporadic disease with no distinct family history, and it arises from noninherited gene mutations, which are not germline, but somatic mutations [51]. This can be related to the model of autosomal dominant inheritance with incomplete penetrance [52]. Some cases of familiarity with venous malformations led Tian et al. to conduct a genetic analysis to recognize mutations related to KTW. They have demonstrated the involvement of a defect of an angiogenic factor, the VG5Q. The first mutation was a translocation t (5;11), which promotes the VG5Q transcription; the second was mutation E133K, which is a functional mutation that substantially enhances the angiogenic effect of VG5Q, the latter promoting the endothelial proliferation. This factor was found in 5 of 130 affected patients, but never in 200 controls [52].
Wang et al. found one case of KTW syndrome associated with translocation involving chromosomes 8q22.3 and 14q13 [52]. Puiu et al. [53] found a terminal deletion 2q37.3, associated with mental delay.
Prenatal diagnosis of KTW syndrome can be challenging, because ultrasound scans cannot recognize most of the typical anomalies. The hallmarks of the prenatal diagnosis of KTW are cutaneous or subcutaneous cystic areas and limb hypertrophy. Other features may be seen prenatally, such as complex soft‐tissue masses that affect unusual areas (e.g., head, neck, or trunk), nonimmune hydrops fetalis, cardiomegaly, and polyhydramnios [26, 27, 54]. Frequently, it presents in the second trimester, mostly unilateral (72%). When localized in the sacral region, the anomaly can be easily confused with a teratoma [26].
Less than 50 cases of prenatal diagnosis of KTW are described in the literature. While the syndrome can be easily diagnosed in the postnatal life with clinical criteria, skin manifestation (such as port wine stain) cannot be seen in prenatal life. Thus, lateral embryonic vein persistence, which is considered pathognomonic of the syndrome, cannot be diagnosed with fetal ultrasound.
According to prenatal series, our review confirmed the most typical ultrasound future, which is the soft‐tissue lesion (generally involving one leg, most frequently the right side), corresponding to hemangioma and/or lymphatic lesion, leading to isolated limb hypertrophy, with either no flow in case of lymphatic malformation or very low‐velocity blood flow in case of capillary and venous malformation. According to our review, in almost all cases (83%), a hemihypertrophy is found, with one leg site of anechoic and/or mixed lesion. Rarely, the lesion can extend toward the thorax and involve upper limbs and the neck.
In this case, an accurate ultrasound examination of the fetus is necessary to exclude associated anomalies. In fact, while the involvement of internal organs by the lymphovascular lesions was found in 15% of cases, in about 37% of cases, there is an association with other anomalies, first of all, limb anomalies.
Hydrops are not frequent but lead to a bad prognosis. Anyway, prenatal complications, such as hydrops, polyhydramnios, cardiac failure and anemia can appear later in pregnancy, which is why ultrasound follow‐up is necessary.
Although a specific genetic mutation has not been found, genetic counseling and prenatal invasive testing diagnosis should be offered to the couple. More studies are necessary to relate KTW syndrome to a specific mutation related to vascular growth factors, but prenatal diagnosis can be useful for differential diagnosis with Proteus syndrome.
The mortality rate is high (37%) and is mostly related to Kasabach‐Merritt syndrome development. Of the newborns survived, and in most cases, the need for treatment is not reported.
5. Conclusions
Prenatal manifestations of KTW are variable, but in the presence of cystic lesions of the legs, eventually extending toward the trunk or upper limbs, or involving internal organs, with no clear origin, this syndrome must be considered in differential diagnosis. Moreover, the association with limb anomalies, efforts the KTW suspicion.
Prenatal and genetic counseling is necessary to guide the couple in the decision whether to continue or not the pregnancy and, in the latter case, to program birth in a second‐ or third‐level center, and postnatal clinical and/or surgical follow‐up.
Ethics Statement
The authors have nothing to report.
Conflicts of Interest
The authors declare no conflicts of interest.
[Correction added on 13 December 2024, after first online publication: The order of author first names and surnames been been corrected in this version.]
Data Availability Statement
The data that support the findings of this study are available from the corresponding author uponreasonable request.
References
- 1. Lee A., Driscoll D., Gloviczki P., Clay R., Shaughnessy W., and Stans A., “Evaluation and Management of Pain in Patients With Klippel‐Trenaunay Syndrome: A Review,” Pediatrics 115 (2005): 744–749. [DOI] [PubMed] [Google Scholar]
- 2. Gloviczki P. and Driscoll D. J., “Klippel‐Trenaunay syndrome: current management,” Phlebology 22 (2007): 291–298. [DOI] [PubMed] [Google Scholar]
- 3. Jacob A. G., Driscoll D. J., Shaughnessy W. J., Stanson A. W., Clay R. P., and Gloviczki P., “Klippel‐Trénaunay syndrome: spectrum and management,” Mayo Clinic Proceedings 73, no. 1 (1998): 28–36. [DOI] [PubMed] [Google Scholar]
- 4. Assimakopoulos E., Zafrakas M., Athanasiades A., Peristeri V., Tampakoudis P., and Bontis J., “Klippel‐Trenaunay‐Weber Syndrome With Abdominal Hemangiomata Appearing on Ultrasound Examination as Intestinal Obstruction,” Ultrasound in Obstetrics & Gynecology 22, no. 5 (2003): 549–550. [DOI] [PubMed] [Google Scholar]
- 5. Gică N., Dumitru A., Panaitescu A. M., et al., “Prenatal Ultrasound Diagnosis of Klippel‐Trenaunay Syndrome,” Diagnostics (Basel) 13, no. 22 (2023): 3400. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. Singh N., Mandelia A., Nigam N., Yadav S., and Pradhan M., “Fetal Klippel‐Trenaunay‐Weber Syndrome: Antenatal Diagnosis and Postnatal Management,” Journal of Indian Association of Pediatric Surgeons 28, no. 5 (2023): 387–391. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Peng H. H., Wang T. H., Chao A. S., Chang Y. L., Shieh S. C., and Chang S. D., “Klippel‐Trenaunay‐Weber Syndrome Involving Fetal Thigh: Prenatal Presentations and Outcomes,” Prenatal Diagnosis 26, no. 9 (2006): 825–830. [DOI] [PubMed] [Google Scholar]
- 8. Cakiroglu Y., Doğer E., Yildirim Kopuk S., Dogan Y., Calıskan E., and Yucesoy G., “Sonographic Identification of Klippel‐Trenaunay‐Weber Syndrome,” Case Reports in Obstetrics and Gynecology 2013 (2013): 595476. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Pang H. Q. and Gao Q. Q., “Prenatal Ultrasonographic Findings in Klippel‐Trenaunay Syndrome: A Case Report,” World Journal of Clinical Cases 9, no. 35 (2021): 10994–10998. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Tanaka K., Miyazaki N., Matsushima M., et al., “Prenatal Diagnosis of Klippel‐Trenaunay‐Weber Syndrome With Kasabach‐Merritt Syndrome In Utero,” Journal of Medical Ultrasonics 42, no. 1 (2001): 109–112. [DOI] [PubMed] [Google Scholar]
- 11. Yu D., Sun L., and Chen T., “Prenatal Ultrasound Diagnosis of Klippel‐Trenaunay‐Weber Syndrome Associated With Umbilical Cord Hemangioma,” Journal of Clinical Ultrasound 49, no. 3 (2021): 254–256. [DOI] [PubMed] [Google Scholar]
- 12. Paladini D., Lamberti A., Teodoro A., et al., “Prenatal Diagnosis and Hemodynamic Evaluation of Klippel‐Trenaunay‐Weber Syndrome,” Ultrasound in Obstetrics & Gynecology 12, no. 3 (1998): 215–217. [DOI] [PubMed] [Google Scholar]
- 13. Heydanus R., Wladimiroff J. W., Brandenburg H., Gaillard J. L., Stewart P. A., and Niermeijer M. F., “Prenatal Diagnosis of Klippel‐Trenaunay‐Weber Syndrome: A Case Report,” Ultrasound in Obstetrics & Gynecology 2, no. 5 (1992): 360–363. [DOI] [PubMed] [Google Scholar]
- 14. Chen C. P., Lin S. P., Chang T. Y., et al., “Prenatal Sonographic Findings of Klippel‐Trénaunay‐Weber Syndrome,” Journal of Clinical Ultrasound 35, no. 7 (2007): 409–412. [DOI] [PubMed] [Google Scholar]
- 15. Gonçalves L. F., Rojas M. V., Vitorello D., Pereira E. T., Pereima M., and Neto J. A. S., “Prenatal Diagnosis of the Klippel‐Trenaunay‐Weber Syndrome,” Prenatal Diagnosis 14, no. 10 (1994): 989–992. [DOI] [PubMed] [Google Scholar]
- 16. Gonçalves L. F., Rojas M. V., Vitorello D., Pereira E. T., Pereima M., and Saab Neto J. A., “Klippel‐Trenaunay‐Weber Syndrome Presenting as Massive Lymphangiohemangioma of the Thigh: Prenatal Diagnosis,” Ultrasound in Obstetrics & Gynecology 15, no. 6 (2000): 537–541. [DOI] [PubMed] [Google Scholar]
- 17. Sahinoglu Z., Uludogan M., and Delikara N. M., “Prenatal Sonographic Diagnosis of Klippel‐Trenaunay‐Weber Syndrome Associated With Umbilical Cord Hemangioma,” American Journal of Perinatology 20, no. 1 (2003): 1–6. [DOI] [PubMed] [Google Scholar]
- 18. Drose J. A., Thickman D., Wiggins J., and Haverkamp A. B., “Fetal Echocardiographic Findings in the Klippel‐Trenaunay‐Weber Syndrome,” Journal of Ultrasound in Medicine 10, no. 9 (1991): 525–527. [DOI] [PubMed] [Google Scholar]
- 19. Warhit J. M., Goldman M. A., Sachs L., Weiss L. M., and Pek H., “Klippel‐Trenaunay‐Weber Syndrome: Appearance In Utero,” Journal of Ultrasound in Medicine 2, no. 11 (1983): 515–518. [DOI] [PubMed] [Google Scholar]
- 20. Coombs P. R., James P. A., and Edwards A. G., “Sonographic Identification of Lower Limb Venous Hypoplasia in the Prenatal Diagnosis of Klippel‐Trénaunay Syndrome,” Ultrasound in Obstetrics & Gynecology 34, no. 6 (2009): 727–729. [DOI] [PubMed] [Google Scholar]
- 21. Hatjis C. G., Philip A. G., Anderson G. G., and Mann L. I., “The In Utero Ultrasonographic Appearance of Klippel‐Trenaunay‐Weber Syndrome,” American Journal of Obstetrics and Gynecology 139, no. 8 (1981): 972–974. [DOI] [PubMed] [Google Scholar]
- 22. Hayashi M., Kurishita M., Sodemodo T., Kozu H., Kumasaka T., and Saiki S., “Prenatal Ultrasonic Appearance of the Klippel‐Trenaunay‐Weber Syndrome Mimicking Sacrococcygeal Teratoma With an Elevated Level of Maternal Serum hCG,” Prenatal Diagnosis 13, no. 12 (1993): 1162–1163. [DOI] [PubMed] [Google Scholar]
- 23. Ivanitskaya O., Andreeva E., and Odegova N., “Prenatal Diagnosis of Klippel‐Trenaunay Syndrome: Series of Four Cases and Review of the Literature,” Ultrasound 28, no. 2 (2020): 91–102. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24. Lewis B. D., Doubilet P. M., Heller V. L., Bierre A., and Bieber F. R., “Cutaneous and Visceral Hemangiomata in the Klippel‐Trenaunay‐Weber Syndrome: Antenatal Sonographic Detection,” AJR. American Journal of Roentgenology 147, no. 3 (1986): 598–600. [DOI] [PubMed] [Google Scholar]
- 25. Meholic A. J., Freimanis A. K., Stucka J., and LoPiccolo M. L., “Sonographic In Utero Diagnosis of Klippel‐Trenaunay‐Weber Syndrome,” Journal of Ultrasound in Medicine 10, no. 2 (1991): 111–114. [DOI] [PubMed] [Google Scholar]
- 26. Meizner I., Rosenak D., Nadjari M., and Maor E., “Sonographic Diagnosis of Klippel‐Trenaunay‐Weber Syndrome Presenting as a Sacrococcygeal Mass at 14 to 15 weeks' Gestation,” Journal of Ultrasound in Medicine 13, no. 11 (1994): 901–904. [DOI] [PubMed] [Google Scholar]
- 27. Mor Z., Schreyer P., Wainraub Z., Hayman E., and Caspi E., “Nonimmune Hydrops Fetalis Associated With Angioosteohypertrophy (Klippel‐Trenaunay) Syndrome,” American Journal of Obstetrics and Gynecology 159, no. 5 (1988): 1185–1186. [DOI] [PubMed] [Google Scholar]
- 28. Seoud M., Santos‐Ramos R., and Friedman J. M., “Early Prenatal Ultrasonic Findings in Klippel‐Trenaunay‐Weber Syndrome,” Prenatal Diagnosis 4, no. 3 (1984): 227–230. [DOI] [PubMed] [Google Scholar]
- 29. Shalev E., Romano S., Nseir T., and Zuckerman H., “Klippel‐Trenaunay syndrome: ultrasonic prenatal diagnosis,” Journal of Clinical Ultrasound 16, no. 4 (1988): 268–270. [DOI] [PubMed] [Google Scholar]
- 30. Yancey M. K., Lasley D., and Richards D. S., “An Unusual Neck Mass in a Fetus With Klippel‐Trenaunay‐Weber Syndrome,” Journal of Ultrasound in Medicine 12, no. 12 (1993): 779–782. [DOI] [PubMed] [Google Scholar]
- 31. Yankowitz J., Slagel D. D., and Williamson R., “Prenatal Diagnosis of Klippel‐Trénaunay‐Weber Syndrome by Ultrasound,” Prenatal Diagnosis 14, no. 8 (1994): 745–749. [DOI] [PubMed] [Google Scholar]
- 32. Zoppi M. A., Ibba R. M., Floris M., Putzolu M., Crisponi G., and Monni G., “Prenatal Sonographic Diagnosis of Klippel‐Trénaunay‐Weber Syndrome With Cardiac Failure,” Journal of Clinical Ultrasound 29, no. 7 (2001): 422–426. [DOI] [PubMed] [Google Scholar]
- 33. Shih J. C., Shyu M. K., Chang C. Y., et al., “Application of the Surface Rendering Technique of Three‐Dimensional Ultrasound in Prenatal Diagnosis and Counselling of Klippel‐Trenaunay‐Weber Syndrome,” Prenatal Diagnosis 18, no. 3 (1998): 298–302. [DOI] [PubMed] [Google Scholar]
- 34. Christenson L., Yankowitz J., and Robinson R., “Prenatal Diagnosis of Klippel‐Trénaunay‐Weber Syndrome as a Cause for In Utero Heart Failure and Severe Postnatal Sequelae,” Prenatal Diagnosis 17, no. 12 (1997): 1176–1180. [PubMed] [Google Scholar]
- 35. Roberts R. V., Dickinson J. E., Hugo P. J., and Barker A., “Prenatal Sonographic Appearances of Klippel‐Trenaunay‐Weber Syndrome,” Prenatal Diagnosis 19, no. 4 (1999): 369–371. [PubMed] [Google Scholar]
- 36. Martin W. L., Ismail K. M., Brace V., McPherson L., Chapman S., and Kilby M. D., “Klippel‐Trenaunay‐Weber (KTW) Syndrome: The Use of In Utero Magnetic Resonance Imaging (MRI) in a Prospective Diagnosis,” Prenatal Diagnosis 21, no. 4 (2001): 311–313. [DOI] [PubMed] [Google Scholar]
- 37. Mejia C. A. E., Ramirez J., Medina O., et al., “Klippel–Trenaunay–Weber syndrome,” 2000, https://sono‐world.com/TheFetus/page.aspx?id1/4423.
- 38. Volkov A., Matsionis A., Voloshin V., et al., “Klippel–Trenaunay–Weber Syndrome,” 2009, https://sono‐world.com/TheFetus/page.aspx?id/2639.
- 39. Al‐Asali O., Abo‐Almaged I., Al Taher A., et al., “Klippel–Trenaunay–Weber Syndrome Case of the Week #286,” https://sono‐world.com/TheFetus/case.aspx?id1/42861.
- 40. Abell K., Tolusso L., Smith N., et al., “Prenatal Diagnosis of Proteus Syndrome: Diagnosis of an AKT1 Mutation From Amniocytes,” Birth Defects Research 112, no. 19 (2020): 1733–1737, 10.1002/bdr2.1801. Epub 2020 Sep 15. [DOI] [PubMed] [Google Scholar]
- 41. International Society for the Study of Vascular Anomalies© , Classification of Vascular Anomalies (Milwaukee, WI, US: ISSVA, 2014). [Google Scholar]
- 42. Güngor Gündoğan T., “Jacquemyn Y Klippel‐Trenaunay Syndrome and Pregnancy,” Obstetrics and Gynecology International 2010 (2010): 706850. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43. Oduber C. E., Van Der Horst C. M., and Hennekam R. C., “Klippel–Trenaunay Syndrome: Diagnostic Criteria and Hypothesis on Eti‐Ology,” Annals of Plastic Surgery 60 (2008): 217–223. [DOI] [PubMed] [Google Scholar]
- 44. Timur A. A., Driscoll D. J., and Wang Q., “Biomedicine and Diseases: The Klippel‐Trenaunay Syndrome, Vascular Anomalies and Vascular Morphogenesis,” Cellular and Molecular Life Sciences 62, no. 13 (2005): 1434–1447. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45. Cha S. H., Romeo M. A., and Neutze J. A., “Visceral Manifestations of Klippel‐Trénaunay Syndrome,” Radiographics 25, no. 6 (2005): 1694–1697, 10.1148/rg.256055042. [DOI] [PubMed] [Google Scholar]
- 46. Wilson C. L., Song L. M., Chua H., et al., “Bleeding From Cavernous Angiomatosis of the Rectum in Klippel‐Tre'naunay Syndrome: Report of Three Cases and Literature Review,” American Journal of Gastroenterology 96 (2001): 2783–2788. [DOI] [PubMed] [Google Scholar]
- 47. Husmann D. A., Rathburn S. R., and Driscoll D. J., “Klippel‐Trenaunay Syndrome: Incidence and Treatment of Genitourinary Sequelae,” Journal of Urology 177, no. 4 (2007): 1244–1249. [DOI] [PubMed] [Google Scholar]
- 48. Anlar B. and Erzen C., “Yalaz K Klippel‐Trenaunay‐Weber Syndrome: A Case With Cerebral and Cerebellar Hemihypertrophy,” Neuroradiology 30 (1988): 360. [DOI] [PubMed] [Google Scholar]
- 49. Redondo P., Aguado L., and Martinez‐Cuesta A., “Diagnosis and Management of Extensive Vascular Malformations of the Lower Limb. Part I. Clinical Diagnosis,” Journal of the American Academy of Dermatology 65 (2011): 893–906. [DOI] [PubMed] [Google Scholar]
- 50. Happel R., “Klippel‐Trénaunay syndrome: is it a paradominant trait?,” British Journal of Dermatology 1228 (1993): 465–466. [DOI] [PubMed] [Google Scholar]
- 51. Tian X. L., Kadaba R., You S. A., et al., “Identification of an Angiogenic Factor That When Mutated Causes Susceptibility to Klippel‐Trenaunay Syndrome,” Nature 427, no. 6975 (2004): 640–645. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52. Wang Q., Timur A. A., Szafranski P., et al., “Identification and Molecular Characterization of de Novo Translocation t (8;14) (q22.3;q13) Associated With a Vascular and Tissue Overgrowth Syndrome,” Cytogenetics and Cell Genetics 95, no. 3–4 (2001): 183–188. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53. Puiu I., Stoica A., Sosoi S., Puiu A., Ioana M., and Burada F., “Terminal Deletion 2q37.3 in a Patient With Klippel‐Trenaunay‐Weber Syndrome,” Fetal and Pediatric Pathology 32 (2013): 351–356. [DOI] [PubMed] [Google Scholar]
- 54. Drose J. A., Thickman D., and Wiggins J., “Fetal Echocardiographic Findings in the Klippel‐Trenaunay‐Weber Syndrome,” Journal of Ultrasound in Medicine 10, no. 9 (1991): 525–527. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
The data that support the findings of this study are available from the corresponding author uponreasonable request.
